Free Trial

Nutrien Ltd. (NYSE:NTR) Shares Acquired by Metis Global Partners LLC

Nutrien logo with Basic Materials background

Metis Global Partners LLC boosted its position in Nutrien Ltd. (NYSE:NTR - Free Report) by 51.3% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 124,317 shares of the company's stock after acquiring an additional 42,167 shares during the period. Metis Global Partners LLC's holdings in Nutrien were worth $5,974,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently modified their holdings of the company. Lester Murray Antman dba SimplyRich boosted its stake in Nutrien by 2.3% during the second quarter. Lester Murray Antman dba SimplyRich now owns 9,069 shares of the company's stock worth $461,000 after acquiring an additional 202 shares in the last quarter. FFT Wealth Management LLC grew its position in Nutrien by 0.8% in the 2nd quarter. FFT Wealth Management LLC now owns 29,220 shares of the company's stock worth $1,488,000 after purchasing an additional 220 shares during the period. Covestor Ltd increased its position in Nutrien by 33.3% during the first quarter. Covestor Ltd now owns 932 shares of the company's stock valued at $50,000 after acquiring an additional 233 shares during the last quarter. MONECO Advisors LLC grew its stake in shares of Nutrien by 2.4% during the 2nd quarter. MONECO Advisors LLC now owns 9,791 shares of the company's stock valued at $498,000 after purchasing an additional 233 shares during the period. Finally, Wealth Enhancement Advisory Services LLC increased its position in shares of Nutrien by 6.5% during the 3rd quarter. Wealth Enhancement Advisory Services LLC now owns 4,309 shares of the company's stock valued at $207,000 after purchasing an additional 263 shares during the last quarter. Hedge funds and other institutional investors own 63.10% of the company's stock.

Nutrien Stock Down 0.9 %

NYSE:NTR traded down $0.44 during trading hours on Thursday, reaching $46.37. The company's stock had a trading volume of 3,937,317 shares, compared to its average volume of 1,969,009. Nutrien Ltd. has a 12 month low of $44.65 and a 12 month high of $60.87. The stock has a 50 day moving average price of $47.99 and a two-hundred day moving average price of $50.50. The company has a market capitalization of $22.90 billion, a P/E ratio of 31.42, a price-to-earnings-growth ratio of 1.61 and a beta of 0.82. The company has a debt-to-equity ratio of 0.38, a quick ratio of 0.82 and a current ratio of 1.27.

Nutrien (NYSE:NTR - Get Free Report) last issued its quarterly earnings data on Wednesday, November 6th. The company reported $0.39 earnings per share for the quarter, missing analysts' consensus estimates of $0.43 by ($0.04). The firm had revenue of $5.35 billion during the quarter, compared to analyst estimates of $5.26 billion. Nutrien had a return on equity of 6.99% and a net margin of 2.79%. The company's revenue was down 5.0% on a year-over-year basis. During the same quarter last year, the company posted $0.35 EPS. Equities analysts predict that Nutrien Ltd. will post 3.65 EPS for the current fiscal year.

Nutrien Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, January 17th. Shareholders of record on Tuesday, December 31st will be paid a dividend of $0.939 per share. This represents a $3.76 annualized dividend and a yield of 8.10%. The ex-dividend date of this dividend is Tuesday, December 31st. This is a positive change from Nutrien's previous quarterly dividend of $0.54. Nutrien's dividend payout ratio (DPR) is 144.97%.

Wall Street Analyst Weigh In

NTR has been the subject of several recent research reports. Wells Fargo & Company lowered Nutrien from an "overweight" rating to an "equal weight" rating and cut their price target for the company from $62.00 to $50.00 in a report on Tuesday, September 24th. The Goldman Sachs Group lowered shares of Nutrien from a "buy" rating to a "neutral" rating and reduced their target price for the stock from $69.00 to $53.00 in a report on Tuesday, September 10th. Hsbc Global Res downgraded shares of Nutrien from a "hold" rating to a "moderate sell" rating in a research report on Friday, August 2nd. Barclays cut their price target on Nutrien from $68.00 to $55.00 and set an "overweight" rating for the company in a research note on Friday, August 16th. Finally, Mizuho decreased their price target on shares of Nutrien from $55.00 to $52.00 and set a "neutral" rating on the stock in a research note on Thursday, August 8th. Three research analysts have rated the stock with a sell rating, six have issued a hold rating and ten have given a buy rating to the stock. According to data from MarketBeat, the stock has an average rating of "Hold" and an average target price of $60.33.

Check Out Our Latest Analysis on Nutrien

About Nutrien

(Free Report)

Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.

See Also

Institutional Ownership by Quarter for Nutrien (NYSE:NTR)

Should you invest $1,000 in Nutrien right now?

Before you consider Nutrien, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nutrien wasn't on the list.

While Nutrien currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Own Before the 2024 Election Cover

Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

’Best Report in 2 Years’: NVIDIA Earnings Crushes Expectations Again
Palantir and the NASDAQ 100: What’s the Next Big Stock Swing for This AI Giant?
Rocket Lab Stock Explodes Higher—What’s Next for This Space Pioneer?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines